The effect of use of Laser Therapy in Allergic Rhinitis: randomized clinical trial
- Conditions
- Allergic RhinitisC20.543
- Registration Number
- RBR-7j4tfdg
- Lead Sponsor
- Pontifícia Universidade Católica do Paraná
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Patients between 18 and 59 years old; Confirmed diagnosis of allergic rhinitis by medical history and positive specific IgE test
Not completing the follow-up period; History of previous nasal surgery; History of antibiotic use for acute illnesses or purulent nasal secretions in the last 4 weeks prior to the start of the research; Ongoing/active upper airway infection (URTI); Inability to complete the test; Asthma; Anosmia; Nasofibroscopy with polyps; Incomplete high school; History of traumatic brain injury; Women with a UPSIT score less than or equal to 18; Men with a UPSIT score less than or equal to 16; Pregnant and breastfeeding women; Use of antihistamines in the last 30 days; Use of corticosteroids in the last 30 days; Use of vasoconstrictor in the last 30 days; Patients with psychiatric or neurological disorders
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine the effectiveness of using photobiomodulation therapy in patients with allergic rhinitis.
- Secondary Outcome Measures
Name Time Method Assess olfactory function before treatment, 1 month after starting treatment using the olfactory test (UPSIT);Assess nasal obstruction using Peak Nasal Inspiratory Flow (PNIF) 1 month after starting treatment.;Assess the symptoms experienced in the last week using the Rhinitis Control Assessment Test (RCAT) 1 month after starting treatment.;Assess Nasal Obstruction Symptoms using the Scale (NOSE) 1 month after starting treatment.